Literature DB >> 1865816

Major limb replantation in children.

J P Daigle1, J M Kleinert.   

Abstract

This retrospective study evaluated patients under 18 years of age who underwent major limb replantation between 1976 and 1989 at Louisville Hand Surgery. The age of the 15 patients followed for between 1 and 8.5 years (mean 4.2 years) ranged from 2 to 17 years (mean 9.8). Of amputations, 40% were guillotine, 40% were limited crush-avulsions, 7% were extended crushing, and eight were of an upper extremity and seven of a lower extremity. Average warm/total ischemia times were 4.8/14.8 hr in failures and 1.1/7.5 hours in successful replantation. Overall limb survival was 87%. Among the patients, 93% felt that their replanted limb functioned and looked better than a prosthesis; 87% of patients had a sensory recovery of more than S2+ in the lower extremity or S3 in the upper extremity; and 38% of upper extremity replantation patients had two-point discrimination of less than 15 mm.

Entities:  

Mesh:

Year:  1991        PMID: 1865816     DOI: 10.1002/micr.1920120312

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  4 in total

1.  A tale of two novel transplants not done: the ethics of limb allografts.

Authors:  David Benatar; Don A Hudson
Journal:  BMJ       Date:  2002-04-20

2.  Above-the-knee replantation in a child: a case report with a 24-year follow-up.

Authors:  Claire Marie C Durban; Seung-Yup Lee; Hong-Chul Lim
Journal:  Strategies Trauma Limb Reconstr       Date:  2015-11-12

Review 3.  Case report and literature review of the outcome following reimplantation of the arm.

Authors:  Cary Fletcher
Journal:  Trauma Surg Acute Care Open       Date:  2017-09-11

4.  Risk and prognostic factors of replantation failure in patients with severe traumatic major limb mutilation.

Authors:  Chang Gao; Ling Yang; Jihui Ju; Ye Gao; Keran Zhang; Mingming Wu; Lijuan Yang; Xiaoting Lu; Ruixing Hou; Qiang Guo
Journal:  Eur J Trauma Emerg Surg       Date:  2022-01-20       Impact factor: 2.374

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.